Barr R D, Rotter D, Koekebakker M
Blut. 1984 Jan;48(1):45-8. doi: 10.1007/BF00320716.
With the aim of determining whether Iscove's Dulbecco's medium (IMDM) provides a growth advantage in the support of granulopoiesis from cultures of human bone marrow in agar, samples from 20 normal subjects were examined in triplicate after 7, 10 and 14 days in parallel cultures containing IMDM or Dulbecco's medium. From every sample, more granulocyte-macrophage colonies were obtained at each culture interval with IMDM. In particular, the number of colonies with IMDM at 14 days (96 +/- 13 per 2x10(5) bone marrow cells) was almost double that with Dulbecco's medium (50 +/- 10). This increment consisted almost entirely of pure granulocyte colonies (P less than 0.001). No significant change in the proportion of eosinophil colonies was observed. These data indicate that IMDM does provide a growth advantage over Dulbecco's medium in the generation of granulocyte (neutrophil and eosinophil) colonies from agar cultures of normal human bone marrow.
为了确定伊思科夫改良杜氏培养基(IMDM)在支持人骨髓琼脂培养物中的粒细胞生成方面是否具有生长优势,对20名正常受试者的样本在含有IMDM或杜氏培养基的平行培养物中培养7、10和14天后进行了一式三份的检测。在每个培养间隔,使用IMDM从每个样本中获得的粒细胞 - 巨噬细胞集落更多。特别是在14天时,使用IMDM的集落数(每2×10⁵个骨髓细胞中96±13个)几乎是使用杜氏培养基的两倍(50±10个)。这种增加几乎完全由纯粒细胞集落组成(P<0.001)。未观察到嗜酸性粒细胞集落比例的显著变化。这些数据表明,在从正常人骨髓琼脂培养物中生成粒细胞(中性粒细胞和嗜酸性粒细胞)集落方面,IMDM确实比杜氏培养基具有生长优势。